Litcius/Paper detail

Bempedoic acid for high-risk patients with CVD as adjunct lipid-lowering therapy: A cost-effectiveness analysis

Kanila Perera, Ning Kam, Zanfina Ademi, Danny Liew, Ella Zomer

2020Journal of clinical lipidology21 citationsDOI

Topics & Concepts

MedicineQuality-adjusted life yearRegimenCost effectivenessInternal medicineRisk analysis (engineering)Lipoproteins and Cardiovascular HealthCoronary Interventions and DiagnosticsHIV-related health complications and treatments
Bempedoic acid for high-risk patients with CVD as adjunct lipid-lowering therapy: A cost-effectiveness analysis | Litcius